You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

First-line therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Colorectal Cancer Trial in Tai'an (Tas-102(Suyuan) combined with bevacizumab)

Not yet recruiting
  • Colorectal Cancer
  • Tas-102(Suyuan) combined with bevacizumab
  • Tai'an, Shandong, China
    The Second Affiliated Hospital of Shandong First Medical Univers
Oct 14, 2023

Colorectal Cancer Trial in Shanghai (Fruquintinib+mFOLFOX6/FOLFIRI)

Recruiting
  • Colorectal Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 23, 2023

Stomach Tumors Trial in Shanghai (Fruquintinib, Sintilimab)

Active, not recruiting
  • Stomach Neoplasms
  • Shanghai, China
    Renji Hospital
Apr 3, 2023

Colorectal Cancer Trial (cadonilimab, irinotecan, Oxaliplatin)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Apr 20, 2023

Advanced Hepatocellular Carcinoma Trial in Guangzhou (adebrelimab, camrelizumab plus apatinib)

Not yet recruiting
  • Advanced Hepatocellular Carcinoma
  • adebrelimab, camrelizumab plus apatinib
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital
Jun 21, 2023

TNBC Trial in Shanghai (PM8002, nab-paclitaxel)

Recruiting
  • TNBC
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Jun 25, 2023

Pleural Mesothelioma Trial in Guangzhou (Cadonilimab+Bevacizumab+Pemetrexed+Carboplatin)

Not yet recruiting
  • Pleural Mesothelioma
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Jul 3, 2023

Unrescetable Hepatocellular Carcinoma Trial in Tianjin (HAIC+Durvalumab+Tremelimumab+Bevacizumab)

Not yet recruiting
  • Unrescetable Hepatocellular Carcinoma
  • Tianjin, Tianjin, China
    Tianjin Cancer Hospital Airport Hospital
May 16, 2023

Unrescetable Hepatocellular Carcinoma Trial in Tianjin (HAIC+Cadonilimab+Bevacizumab)

Not yet recruiting
  • Unrescetable Hepatocellular Carcinoma
  • Tianjin, Tianjin, China
    Tianjin Cancer Hospital Airport Hospital
Apr 7, 2023

Intrahepatic Cholangiocarcinoma Trial in Shanghai (Cadonilimab+Gem/Cis)

Active, not recruiting
  • Intrahepatic Cholangiocarcinoma
  • Shanghai, Shanghai, China
    Eastern hepatobilliary surgery hospital
Mar 22, 2023

Hepatocellular Carcinoma Trial in Hangzhou (PM8002, FOLFOX regimen)

Recruiting
  • Hepatocellular Carcinoma
  • PM8002
  • FOLFOX regimen
  • Hangzhou, Zhejiang, China
    Cancer Hospital of The University of Chinese Academy of Sciences
May 19, 2023

Biliary Tract Carcinoma Trial in Beijing (Gemcitabine, S1, Tislelizumab)

Not yet recruiting
  • Biliary Tract Carcinoma
  • Beijing, China
    Chinese Academy of Medical Sciences & Peking Union Medical Colle
Apr 10, 2023

Efficacy and Safety of ICIs as First-line Therapy for Advanced

Not yet recruiting
  • Malignant Tumor
  • +2 more
    • Chongqing, Chongqing, China
      the second affiliated hospital of Army medical university
    May 16, 2023

    Metastatic Uveal Melanoma Trial in Grand Rapids (IDE196, Crizotinib, Pembrolizumab)

    Recruiting
    • Metastatic Uveal Melanoma
    • Grand Rapids, Michigan
      The Cancer and Hematology Centers
    Aug 14, 2023

    NSCLC Trial in Chendu (Almonertinib)

    Recruiting
    • Non-small Cell Lung Cancer
    • Chendu, Sichuan, China
      West China Hospital，Sichuan University
    Dec 14, 2022

    Japanese RCC Patients Treated With Avelumab Plus Axitinib as

    Not yet recruiting
    • Renal Cell Carcinoma
    • (no location specified)
    Jan 18, 2023

    Oral Cavity Squamous Cell Carcinoma Trial in Yichang (Sintilimab, Radiotherapy)

    Recruiting
    • Oral Cavity Squamous Cell Carcinoma
    • Yichang, Hubei, China
      Department of Medical Oncology, Central Hospital of Yichang City
    Feb 18, 2023

    MPM Trial in Changchun (PM8002, Pemetrexed, Cisplatin)

    Recruiting
    • MPM
    • Changchun, China
      Jilin Provincial Tumor Hospital
    Jun 25, 2023

    Chronic GVHD Trial in Shanghai (SHR0302, Prednisone)

    Recruiting
    • Chronic GVHD
    • Shanghai, Shanghai, China
    • +1 more
    Aug 4, 2022

    Diffuse Large B Cell Lymphoma Trial (Epcoritamab, Lenalidomide)

    Not yet recruiting
    • Diffuse Large B Cell Lymphoma
    • (no location specified)
    Jan 20, 2023

    Small Cell Lung Cancer Extensive Stage Trial (Pembrolizumab, Plinabulin plus Etoposide and Platinum)

    Not yet recruiting
    • Small Cell Lung Cancer Extensive Stage
    • Pembrolizumab, Plinabulin plus Etoposide and Platinum
    • (no location specified)
    Feb 15, 2023

    B-cell Lymphoma Trial in Beijing (Relmacabtagene Autoleucel, Fludarabine, Cyclophosphamide)

    Not yet recruiting
    • B-cell Lymphoma
    • Relmacabtagene Autoleucel
    • +2 more
    • Beijing, Beijing, China
    • +1 more
    Oct 19, 2022

    Metastatic Pancreatic Cancer Trial in Lyon (Niraparib)

    Not yet recruiting
    • Metastatic Pancreatic Cancer
    • Lyon, France
      Centre Léon Bérard
    Jul 4, 2022

    Pancreatic Tumors Trial in Guangzhou (Surufatinib, Sintilimab, AG)

    Not yet recruiting
    • Pancreatic Neoplasms
    • Guangzhou, Guangdong, China
      Cancer center of SunYat-sen University
    Jul 28, 2022

    Leukemia, Chronic Lymphatic Trial in Stuttgart, Tuebingen (Peptide Vaccine, Imiquimod)

    Completed
    • Leukemia, Chronic Lymphatic
    • Stuttgart, Baden-Wuerttemberg, Germany
    • +4 more
    Nov 24, 2022